From the Brain-Skin Connection: The Neuroendocrine-Immune Misalliance of Stress and Itch

Perceived stress has long been allied with disturbances of the dynamic equilibrium established between the nervous, endocrine and immune systems, thus triggering or aggravating disease manifestation. Several common skin diseases are now acknowledged to be worsened by psychological stress, particularly immunodermatoses such as atopic dermatitis, psoriasis, seborrheic eczema, prurigo nodularis, lichen planus, chronic urticaria, alopecia areata and pruritus sine materia. Itch (pruritus) is perhaps the most common symptom associated with a majority of these inflammatory skin diseases, and acute as well as chronic stress perceptions are recognized to trigger or enhance pruritus. A wealth of mediators released systemically or locally in the skin in response to stress increase sensory innervation, upregulate the production of other pruritogenic agents, perpetuate (neurogenic) inflammation and lower the itch threshold. In the present review, we explore recent frontiers in both stress and pruritus research and portray the perpetuation of chronic skin inflammation and itch as a neuroendocrine-immune ‘misalliance’. We argue that key candidate molecules of the stress response with strong pruritogenic potential, such as nerve growth factor, corticotropin-releasing hormone and substance P, and mast cells, which may be considered as ‘central cellular switchboards of pruritogenic inflammation’, need to be further explored systematically in order to develop more effective therapeutic combination strategies for itch management in chronic, stress-vulnerable inflammatory skin diseases

[1]  D. Tobin,et al.  Corticotropin releasing hormone and the skin. , 2006, Frontiers in bioscience : a journal and virtual library.

[2]  M. Yaar,et al.  Neurotrophins in skin biology and pathology. , 2006, The Journal of investigative dermatology.

[3]  M. Steinhoff,et al.  Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. , 2006, The Journal of investigative dermatology.

[4]  P. Arck,et al.  Neuroimmunology of stress: skin takes center stage. , 2006, The Journal of investigative dermatology.

[5]  R. Paus,et al.  Frontiers in pruritus research: scratching the brain for more effective itch therapy. , 2006, The Journal of clinical investigation.

[6]  M. Maurer,et al.  The status quo and quo vadis of mast cells , 2005, Experimental dermatology.

[7]  H. Matsuda,et al.  Expression of nerve growth factor in itchy skins of atopic NC/NgaTnd mice. , 2005, The Journal of veterinary medical science.

[8]  P. Arck,et al.  Mothers in Stress: Consequences for the Offspring , 2005, American journal of reproductive immunology.

[9]  R. Paus,et al.  Human hair follicles display a functional equivalent of the hypothalamic‐pituitary‐adrenal (HPA) axis and synthesize cortisol , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  S. Hunt,et al.  Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition , 2005, Journal of Molecular Medicine.

[11]  E. Sternberg,et al.  Brain-immune interactions and disease susceptibility , 2005, Molecular Psychiatry.

[12]  M. Steinhoff,et al.  How best to fight that nasty itch – from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches , 2005, Experimental dermatology.

[13]  Thomas A Luger,et al.  Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. , 2005, Endocrine reviews.

[14]  J. Wingfield,et al.  The Darwinian concept of stress: benefits of allostasis and costs of allostatic load and the trade-offs in health and disease , 2005, Neuroscience & Biobehavioral Reviews.

[15]  B. McEwen,et al.  Protection and Damage from Acute and Chronic Stress: Allostasis and Allostatic Overload and Relevance to the Pathophysiology of Psychiatric Disorders , 2004, Annals of the New York Academy of Sciences.

[16]  P. Conti,et al.  Mast cells as targets of corticotropin-releasing factor and related peptides. , 2004, Trends in pharmacological sciences.

[17]  F. Shanahan,et al.  The role of substance P in inflammatory disease , 2004, Journal of cellular physiology.

[18]  Robert Dantzer,et al.  Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. , 2004, European journal of pharmacology.

[19]  B. Klapp,et al.  Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. , 2004, The American journal of pathology.

[20]  M. Laudenslager,et al.  Psychoneuroimmunology: then and now. , 2004, Behavioral and cognitive neuroscience reviews.

[21]  Lawrence Steinman,et al.  Elaborate interactions between the immune and nervous systems , 2004, Nature Immunology.

[22]  J. Rees,et al.  Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in BalbC mice , 2004, British journal of pharmacology.

[23]  K. Kandere-Grzybowska,et al.  IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells1 , 2003, The Journal of Immunology.

[24]  M. Steinhoff,et al.  Neuronal sensitization for histamine-induced itch in lesional skin of patients with atopic dermatitis. , 2003, Archives of dermatology.

[25]  T. Kawakami,et al.  Effective treatment of pruritus in atopic dermatitis using H1 antihistamines (second-generation antihistamines): changes in blood histamine and tryptase levels. , 2003, Journal of dermatological science.

[26]  A. Kraneveld,et al.  Functional Expression of Neurokinin 1 Receptors on Mast Cells Induced by IL-4 and Stem Cell Factor1 , 2003, The Journal of Immunology.

[27]  H O Handwerker,et al.  Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. , 2003, Journal of neurophysiology.

[28]  F. Dhabhar,et al.  Stress, Leukocyte Trafficking, and the Augmentation of Skin Immune Function , 2003, Annals of the New York Academy of Sciences.

[29]  B. Klapp,et al.  Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. , 2003, The American journal of pathology.

[30]  U. Gieler,et al.  Psyche and skin: What's new? , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[31]  S. Salvadori,et al.  Pharmacological profile of hemokinin 1: a novel member of the tachykinin family. , 2002, Life sciences.

[32]  G. Chrousos,et al.  Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. , 2002, The Journal of rheumatology.

[33]  O. Johansson,et al.  Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin – an exploration of the cause of neurohyperplasia , 2002, Archives of Dermatological Research.

[34]  Stephen P. Hunt,et al.  The molecular dynamics of pain control , 2001, Nature Reviews Neuroscience.

[35]  J. Wallace,et al.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism , 2000, Nature Medicine.

[36]  P. Klein,et al.  An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. , 1999, Archives of dermatology.

[37]  L. Petersen,et al.  Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells , 1998, Inflammation Research.

[38]  G. Chrousos,et al.  Stressors, Stress, and Neuroendocrine Integration of the Adaptive Response: The 1997 Hans Selye Memorial Lecture , 1998, Annals of the New York Academy of Sciences.

[39]  M. Schedlowski,et al.  Catecholamine-Induced Leukocytosis: Early Observations, Current Research, and Future Directions , 1996, Brain, Behavior, and Immunity.

[40]  G. Chrousos,et al.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.

[41]  Y. Kitamura,et al.  Substance P induces granulocyte infiltration through degranulation of mast cells. , 1989, Journal of immunology.

[42]  R. Stead,et al.  Mast cell involvement in various inflammatory processes. , 1987, The American review of respiratory disease.

[43]  E. Alleva,et al.  Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[44]  E. Farber,et al.  Stress, symmetry, and psoriasis: possible role of neuropeptides. , 1986, Journal of the American Academy of Dermatology.

[45]  R. Carraway,et al.  Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. , 1982, The Journal of physiology.

[46]  J. Gaddum,et al.  An unidentified depressor substance in certain tissue extracts , 1931, The Journal of physiology.

[47]  P. Arck,et al.  Neuroimmunoendocrine circuitry of the 'brain-skin connection'. , 2006, Trends in immunology.

[48]  F. Dhabhar,et al.  How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[49]  S. Raychaudhuri,et al.  Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis. , 2004, Progress in brain research.

[50]  M. Schmelz A neural pathway for itch , 2001, Nature Neuroscience.

[51]  S. Maier,et al.  The pain of being sick: implications of immune-to-brain communication for understanding pain. , 2000, Annual review of psychology.

[52]  G. Chrousos,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society Corticotropin-Releasing Hormone Induces Skin Mast Cell Degranulation and Increased Vascular Permeability, A Possible Explanation for Its Proinflammatory Effects* , 2022 .